# Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus

> **NCT05101915** · PHASE2 · TERMINATED · sponsor: **Papworth Hospital NHS Foundation Trust** · enrollment: 6 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** RESP301

## Key facts

- **NCT ID:** NCT05101915
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-01
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-04-23
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** TSC recommended early termination due to lack of futility of the trial.
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05101915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05101915, "Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05101915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*